Last Updated: September 26, 2023 @ 9:13 am | ||
2939 | Cyclic Citrullinated Peptide 3 Antibody, IgG (CCP3) | |
Specimen: | Collect: |
Also Acceptable:
|
Submit: |
Also Acceptable:
| |
Special Handling: |
| |
Rejection Criteria: |
| |
Stability: | Ambient: 8 Hour(s); Refrigerated: 2 Day(s); Frozen: 1 Month(s); Incubated: Unacceptable | |
Methodology: |
| |
Performed: | Mon-Fri | |
Reported: | 1-3 Day(s) | |
CPT Codes: |
| |
Interpretive Data: | CCP3 Reference Range: <20 Units Negative 20-39 Units Weak Positive 40-59 Units Moderate Positive >59 Units Strong Positive Anti-cyclic citrullinated peptide (anti-CCP), IgG antibodies are present in about 69-83 percent of patients with rheumatoid arthritis (RA) and have specificities of 93-95 percent. These autoantibodies may be present in the preclinical phase of disease, are associated with future RA development, and may predict radiographic joint destruction. Patients with weak positive results should be monitored and testing repeated. | |
Components: |
|
Disclaimer:
It is preferable to locate tests on the website and not rely on printed test information, which may soon be out of date.
Updated test information can only be guaranteed by using this website.